Abstract | OBJECTIVE: METHODS: RESULTS: A dose-dependent reduction in mean arterial pressure from 125 mmHg (95% confidence interval [CI] 117-133) to 103.5 (95% CI 97-111) (P < .005) and an increase in pulse rate from 73.7 beats per minute (95% CI 64.3-84.5) to 89.1 (95% CI 81.2-97.8) (P < .02) was observed during the infusion. Mean uterine artery resistance index fell from 0.76 (95% CI 0.73-0.81) to 0.70 (95% CI 0.65-0.75) (P < .009). Platelet activation measured by P-selectin expression was reduced from 3.02% (95% CI 2.09-4.36) to 1.22% (95% CI 0.94-1.58) (P < .01). Fetal Doppler indices (umbilical artery, middle cerebral artery, and thoracic aorta) showed no significant changes during the infusion. CONCLUSION:
S-nitrosoglutathione infusion reduced material mean arterial pressure, platelet activation, and uterine artery resistance without further compromising fetal Doppler indices. This study suggests that platelet-specific nitric oxide donors may prove beneficial in the management of severe preeclampsia.
|
Authors | C Lees, E Langford, A S Brown, A de Belder, A Pickles, J F Martin, S Campbell |
Journal | Obstetrics and gynecology
(Obstet Gynecol)
Vol. 88
Issue 1
Pg. 14-9
(Jul 1996)
ISSN: 0029-7844 [Print] United States |
PMID | 8684748
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Nitroso Compounds
- Platelet Aggregation Inhibitors
- S-Nitrosoglutathione
- Glutathione
|
Topics |
- Adult
- Blood Pressure
(drug effects)
- Dose-Response Relationship, Drug
- Female
- Glutathione
(analogs & derivatives, therapeutic use)
- Humans
- Nitroso Compounds
(therapeutic use)
- Platelet Activation
(drug effects)
- Platelet Aggregation Inhibitors
(therapeutic use)
- Pre-Eclampsia
(drug therapy)
- Pregnancy
- S-Nitrosoglutathione
- Severity of Illness Index
- Ultrasonography, Prenatal
(drug effects)
|